Monday, November 2, 2026

South Korea’s North Korean Human Rights Policy Needs Bipartisan Consistency

A visit to Iran reshaped perceptions, highlighting shared humanity and the complexities of North Korean human rights discussions in South Korea.

Will Trump and Lee Meet? Key Insights from the Upcoming G7 Summit

President Lee Jae Myung's European tour aims to enhance diplomacy, with a potential U.S.-Korea summit and tariff discussions on the agenda.

South Korea’s Health Minister Pledges Swift Action to Prevent Medical Supply Disruptions

Health Minister Jeong Eun-kyung assures swift action to stabilize medical product supplies amid Middle East conflict concerns.

Health

How Samsung Medical Center Reduced Waste by 80%: A Game-Changer in ESG Management

Hospitals face pressure to adopt eco-friendly practices due to rising concerns over waste and disposable items impacting the environment.

Q901: The Promising New Hope for Pediatric Brain Tumors – What You Need to Know About This FDA-Approved Therapy

Qurient, the major shareholder of DongKoo Bio&Pharma, received FDA approval for a pediatric brain tumor trial of Q901.

IKS014 vs. Enhertu: Can This New HER2 ADC Drug Revolutionize Breast Cancer Treatment?

IKS014 shows a 50% objective response rate in HER2-positive breast cancer patients previously treated with Enhertu.

IMB-105: The Next Breakthrough in Autoimmune Disease Treatment?

IMBiologics partners with GC Pharma to develop next-generation autoimmune disease treatments.

How MEDTIS is Revolutionizing Remote Healthcare in Asia: Insights from Health On Cloud’s CEO

Trust is essential for Korean medical technology to enter foreign markets, according to Jeon Sang-hoon, CEO of Health On Cloud.

Revolutionary Biodegradable Stents for Pets: Meet the First Four Approved by South Korea

M.I. Tech has become the first South Korean company to receive approval for biodegradable stents for pets, addressing traditional stent complications.

HLB Genex and KAIST Join Forces: Revolutionary Brain Health Solutions in 2026

HLB Genex partners with KAIST to develop innovative brain health solutions, merging research with commercialization to address social challenges.

FDA Grants Orphan Drug Status to Tovecimig: What This Means for Cholangiocarcinoma Treatment

ABL Bio's Tovecimig receives Orphan Drug Designation from the FDA, enhancing its approval prospects for cholangiocarcinoma treatment.

Discover the Premium 9-Pin Needle: Revolutionizing Aesthetic Treatments in China

Huons Meditech launches its Premium 9-Pin Needle in China, enhancing aesthetic treatments with innovative design and NMPA certification.

CT-P71: The New ADC Cancer Drug Fast-Tracked by FDA for Urothelial Carcinoma

Celltrion's CT-P71 receives FDA Fast Track designation for urothelial carcinoma, enhancing its ADC pipeline and global drug development efforts.

JW Pharmaceuticals Secures Exclusive Rights for Innovative GLP-1 Drug Vopaglutide in South Korea

JW Pharmaceutical secures exclusive rights for Vopaglutide, a promising treatment for diabetes and obesity, with significant milestone payments.

Revolutionizing Stroke Treatment: How AI is Transforming Care at Korea University Anam Hospital

JLK's stroke AI solution is enhancing clinical efficiency at Korea University Anam Hospital through rapid imaging and data-driven decisions.

AI in Healthcare: AITRICS-VC Gains Approval in Indonesia – What This Means for Patients

AITRICS gains approval for its AI solution VitalCare in Indonesia, aiding early prediction of patient condition deterioration.

Revolutionary AI System Predicts Ventilator Needs for Pediatric Patients: Discover DeePedIMV

Vuno's AI system predicts intubation needs in pediatric patients, improving accuracy and reducing alarm frequency in critical care.

How Artemis 2’s Record-Breaking Journey is Shaping the Future of Space Medicine in Asia

NASA's Artemis 2 mission sparks interest in space medicine, with South Korea's Boryung leading advancements in space-based healthcare solutions.

GC Biopharma Develops Innovative Method to Enhance Immunoglobulin Safety

GC녹십자 developed a method to detect impurities that can cause blood clots in the production of intravenous immunoglobulin.

How SCL Science’s Digital Logistics Platform BIONECT is Revolutionizing the Cold Chain Industry

SCL Science showcased its next-gen bio-logistics platform at the Korea Cold Chain 2026, emphasizing advanced cold chain logistics for healthcare.

SK Biopharmaceuticals Unveils Breakthrough Findings on NTSR1-Targeted Radiopharmaceutical SKL35501

SK Biopharmaceuticals will present findings on NTSR1-targeted treatments at the AACR Annual Meeting, showcasing innovative oncology research.

How Hanmi’s Dual Inhibitor HM97662 is Revolutionizing Cancer Treatment: Key Insights from AACR 2026

Hanmi Pharmaceutical to present nine groundbreaking cancer research studies at AACR 2026, showcasing innovative therapies and AI-driven analytics.

Top News

- Our Sponsors Ad -

Follow us